<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00747669</url>
  </required_header>
  <id_info>
    <org_study_id>EN3274-401</org_study_id>
    <nct_id>NCT00747669</nct_id>
  </id_info>
  <brief_title>Pharmacokinetic Study of Synera™ in Neonates and Infants</brief_title>
  <official_title>A Pharmacokinetic Study of Synera™ (Lidocaine 70 mg and Tetracaine 70 mg Topical Patch) to Evaluate the Systemic Exposure to Lidocaine and Tetracaine in Neonates and Infants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ZARS Pharma Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ZARS Pharma Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will measure the amount of lidocaine and tetracaine in the blood after a 30 minute
      application of Synera.
    </textblock>
  </brief_summary>
  <overall_status>Suspended</overall_status>
  <why_stopped>
    Difficulty with enrollment
  </why_stopped>
  <start_date>September 2008</start_date>
  <completion_date type="Anticipated">April 2013</completion_date>
  <primary_completion_date type="Anticipated">April 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluate the systemic exposure to lidocaine and tetracaine following application of Synera</measure>
    <time_frame>30 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Monitor the nature and frequency of adverse events</measure>
    <time_frame>30 Hours</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">11</enrollment>
  <condition>Pain</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>lidocaine 70mg and tetracaine 70mg topical patch</intervention_name>
    <description>One Synera Patch applied for 30 minutes.</description>
    <other_name>Synera</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject must be an infant of 1 to 4 months of age and weigh at least 2.5 kg or a
             neonate of 0 to 4 weeks postnatal age with a gestation period of at least 37 weeks,
             and weigh at least 1.8 kg.

          -  Subject is scheduled to have a medically indicated minor superficial procedure for
             which topical local anesthesia would provide a benefit.

          -  Subject has or will have an indwelling vascular access catheter for blood sampling at
             the time of the procedure visit. The indwelling vascular access catheter placement
             must be necessary for medical reasons other than the purposes of this study.

          -  The additional blood draws for the purposes of this study do not pose more than a
             minor risk to the health and welfare of the subject.

        Exclusion Criteria:

          -  Subject has known allergies or sensitivities to any component of Synera.

          -  Subject has clinically significant laboratory abnormalities.

          -  Subject has known multiple allergies that could indicate hypersensitive skin.

          -  Subject has known active atopic dermatitis at or near the patch application site.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>4 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ZARS Clinical Development</last_name>
    <role>Study Chair</role>
    <affiliation>ZARS Pharma</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Children's National Medical Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 3, 2008</study_first_submitted>
  <study_first_submitted_qc>September 3, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 5, 2008</study_first_posted>
  <last_update_submitted>March 22, 2012</last_update_submitted>
  <last_update_submitted_qc>March 22, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 23, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Tetracaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

